Table 4.
Variable | Reference range | Pre-race | 12 h running | 24 h running | 48 h running | 24 h post-race | 48 h post-race | ANOVA results | |
---|---|---|---|---|---|---|---|---|---|
Hb [g/dl] | 11.2–15.8 | 13.9 ± 0.9 | 14.2 ± 0.6 | 14.0 ± 0.7 | 14.0 ± 1.0 | 12.2 ± 1.1** | 12.2 ± 1.3** | F 5,30 = 19.8 | p < 10 −3 |
RBC [×106/μl] | 4.0–5.8 | 4.7 ± 0.4 | 4.8 ± 0.3 | 4.7 ± 0.3 | 4.5 ± 0.4 | 4.1 ± 0.5** | 4.1 ± 0.5** | F 5,30 = 22.6 | p < 10 −3 |
HCT [%] | 35–45 | 41 ± 3 | 41 ± 2 | 40 ± 2 | 38 ± 3** | 36 ± 3** | 36 ± 4** | F 5,30 = 15.5 | p < 10 −3 |
PLT [×103/μl] | 130–400 | 238 ± 53 | 283 ± 74* | 276 ± 66** | 261 ± 55 | 219 ± 45 | 213 ± 46 | F 5,30 = 15.6 | p < 10 −3 |
MCV [fl] | 82.0–98.0 | 87.7 ± 3.5 | 85.4 ± 3.2** | 84.7 ± 3.0*** | 85.4 ± 2.9** | 88.1 ± 3.7 | 89.3 ± 4.0* | F 5,30 = 48.5 | p < 10 −3 |
MCH [pg] | 27.0–30.0 | 29.7 ± 1.3 | 29.8 ± 1.2 | 29.8 ± 1.2 | 29.8 ± 1.2 | 30.0 ± 1.3 | 30.1 ± 1.3* | F 5,30 = 5.40 | p = 0.0012 |
MCHC [%] | 34.0–36.0 | 33.9 ± 1.0 | 34.9 ± 0.8** | 35.1 ± 0.9*** | 34.9 ± 0.7* | 34.0 ± 1.0 | 33.8 ± 1.1 | F 5,30 = 30.2 | p < 10 −3 |
WBC [×109/l] | 4.0–10.0 | 5.4 ± 0.8 | 14.9 ± 3.5** | 13.5 ± 2.6*** | 12.9 ± 3.0** | 7.1 ± 2.0 | 6.0 ± 1.5 | F 5,30 = 49.5 | p < 10 −3 |
Neutrophils [× 109/l] | 1.8–7.7 | 3.2 ± 0.5 | 11.3 ± 3.5** | 9.8 ± 2.2** | 9.9 ± 3.3** | 4.6 ± 2.4 | 3.9 ± 1.8 | F 5,30 = 38.0 | p < 10 −3 |
Monocytes [×109/l] | 0–0.8 | 0.5 ± 0.1 | 1.4 ± 0.3*** | 1.5 ± 0.5** | 1.1 ± 0.4** | 0.7 ± 0.2** | 0.6 ± 0.2** | F 5,30 = 37.5 | p < 10 −3 |
Lymphocytes [×109/l] | 1.0–4.5 | 1.6 ± 0.5 | 2.0 ± 0.8 | 2.1 ± 0.9 | 1.8 ± 0.6 | 1.6 ± 0.5 | 1.4 ± 0.5 | F 5,30 = 4.82 | p = 0.0023 |
* p < 0.05, ** p < 0.01, *** p < 0.001 versus the respective pre-race value; the significance levels shown with asterisks refer to p values with the sequential Bonferroni–Holm correction. Statistically significant ANOVA results are shown in boldtype